Search hospitals > Ohio > Columbus
Aventiv Research, Inc.
Claim this profileColumbus, Ohio 43213
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Coronavirus
Conducts research for COVID-19
Conducts research for Osteoarthritis
225 reported clinical trials
5 medical researchers
Summary
Aventiv Research, Inc. is a medical facility located in Columbus, Ohio. This center is recognized for care of Diabetes, Type 2 Diabetes, Coronavirus, COVID-19, Osteoarthritis and other specialties. Aventiv Research, Inc. is involved with conducting 225 clinical trials across 234 conditions. There are 5 research doctors associated with this hospital, such as Andrew W. Pippas, Samir Arora, MD, Sridhar Guduri, MD, and Kenneth R Boren.Top PIs
Andrew W. PippasJohn B Amos Cancer Center8 years of reported clinical research
Studies Uterine Tumors
Studies Breast Cancer
18 reported clinical trials
52 drugs studied
Samir Arora, MDAventiv Research Inc3 years of reported clinical research
Studies Osteoarthritis
Studies Neuropathic Pain
15 reported clinical trials
18 drugs studied
Sridhar Guduri, MDAventiv Research Inc4 years of reported clinical research
Studies Allergic Reaction
Studies Peanut Allergy
14 reported clinical trials
20 drugs studied
Kenneth R BorenPhoenician Centers for Research and Innovation4 years of reported clinical research
Studies Diabetes
Studies Type 1 Diabetes
3 reported clinical trials
4 drugs studied
Clinical Trials running at Aventiv Research, Inc.
Coronavirus
Skin Cancer
Fatty Liver
Non-alcoholic Fatty Liver Disease
COVID-19
Diabetes
Type 2 Diabetes
Obesity
Cardiovascular Disease
Post-COVID Syndrome
COVID-19 Vaccine
for Children
The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy children. The trial is divided into 5 individual studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies will receive study vaccine as a shot depending on what group they are in. * Substudy A design: Phase 1 includes participants 6 months through less than 4 years 3 months of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naïve) and will receive 3 doses of study vaccine as their initial series, followed by a fourth dose of study vaccine. Phase 2/3 includes participants 6 months through less than 5 years of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naive) and will receive 1, 2, or 3 doses of study vaccine, depending on what group they are in. * Substudy B design: includes participants 6 months through less than 5 years of age who have either received 2 or 3 prior doses of BNT162b2 and will receive study vaccine as their third or fourth dose. * Substudy C design: Phase 1 includes participants 6 months through less than 5 years of age who have received 3 prior doses of BNT162b2 and will receive study vaccine as their fourth dose. * Substudy D design: includes participants 5 through less than12 years of age who have received 2 or 3 prior doses of BNT162b2 and will receive study vaccine as their third or fourth dose. * Substudy E design: includes participants 2 through less than 12 years of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naive) and will receive a single dose of study vaccine.
Recruiting1 award Phase 2 & 36 criteria
Flu and COVID-19 Vaccines
for Coronavirus and Influenza
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Aventiv Research, Inc.?
Aventiv Research, Inc. is a medical facility located in Columbus, Ohio. This center is recognized for care of Diabetes, Type 2 Diabetes, Coronavirus, COVID-19, Osteoarthritis and other specialties. Aventiv Research, Inc. is involved with conducting 225 clinical trials across 234 conditions. There are 5 research doctors associated with this hospital, such as Andrew W. Pippas, Samir Arora, MD, Sridhar Guduri, MD, and Kenneth R Boren.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.